One dose of BNT162b2 inadequate for hemodialysis patients
FDA approves third COVID-19 antibody treatment for emergency use
27 May 2021Mass gatherings during Malaysian election directly and indirectly boosted COVID-19 spread
27 May 2021One dose of BNT162b2 inadequate for hemodialysis patients
(HealthDay)—For a majority of hemodialysis patients, a single dose of the BNT162b2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine fails to elicit a humoral response, according to a study published online May 12 in CMAJ, the journal of the Canadian Medical Association.
